RecruitingNCT05922657

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

A Prospective, Observational, Multi-center Study to Gather Real World Use Data on the Effectiveness, Safety, and Site-of-service of the Cerene Device

Sponsor

Channel Medsystems

Enrollment

300 participants

Start Date

Jun 9, 2023

Study Type

OBSERVATIONAL

Conditions

Abnormal Uterine Bleeding Heavy Menstrual Bleeding Menorrhagia

Summary

Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bridge the gap between clinical results and outcomes achieved and reported during the pivotal study of Cerene and those obtained during its real-world use.

Eligibility

Sex: FEMALEMin Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Cerene for people with abnormal uterine bleeding, heavy menstrual bleeding, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 25 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.